Jiaxin Cao
3PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Jun 04, 2024
Influence of TP53 mutation on efficacy and survival in advanced EGFR-mutant non-small cell lung cancer patients treated with third-generation EGFR tyrosine kinase inhibitors.Zhonghan Zhang, Jinhui Xue, Yunpeng Yang
|Mar 30, 2024
PQR309, a dual PI3K/mTOR inhibitor, synergizes with gemcitabine by impairing the GSK-3β and STAT3/HSP60 signaling pathways to treat nasopharyngeal carcinoma.Jiaxin Cao, Kangmei Zeng, Qun Chen
|Feb 01, 2023
Phase I study of camrelizumab in patients with advanced solid tumors.Yuxiang Ma, Jiaxin Cao, Yang Zhang
Pageof 1
